Two-year PULSAR Trial Results for Aflibercept 8 mg Demonstrate Durable Vision Gains at Extended Dosing Intervals in Wet Age-related Macular Degeneration
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of…
Initiation of Phase 2b BEACON-IPF trial of bexotegrast in patients with IPF INTEGRIS-PSC Phase 2a…
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and…
The global modern card issuer had $54 billion in total processing volume, up 33 percent…
Highest Service Revenue Quarter To Date First Quarter of Adjusted EBITDA Profitability Raises Previously Announced…
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®…
— VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within…